Source/Disclosures
Published by:
Source:
Healio Interview
Disclosures:
LaPlante reports research with Merck, Pfizer and Shionogi.
November 11, 2021
1 min watch
Save
VIDEO: Preventing and treating C. difficile infection
Source/Disclosures
Published by:
Source:
Healio Interview
Disclosures:
LaPlante reports research with Merck, Pfizer and Shionogi.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WASHINGTON – In this video, infectious disease pharmacist Kerry LaPlante, PharmD, FCCP, FIDSA, discusses a presentation she gave at the World Anti-Microbial Resistance Congress on Clostridioides difficile infection.
LaPlante, who is department chair and a professor of pharmacy at the University of Rhode Island College of Pharmacy, talked about the importance of infection control and being a good antibiotic steward, and discussed innovations in C. difficile therapy, including fecal microbiota transplantation.
“Please remember to only use antibiotics appropriately and when absolutely necessary,” she said.